ConductScience.org, home

Paper338408

Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.

Hendriksen C and 3 others. Diabetologia, 1977. Cited by 103 papers, by iCite.

Cite this record

ConductScience Library. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon. Papers, record 338408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/338408

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
PubMed
Journal
Diabetologia
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
103
iCite
Relative citation ratio, by iCite
3.89
iCite
Revised in PubMed
2019-08-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hendriksen CC
2Faber OKO K
3Drejer JJ
4Binder CC

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
C-PeptideMajor topic
Diabetes MellitusMajor topic
GlucagonMajor topic
Islets of LangerhansMajor topic
PeptidesMajor topic
Blood Glucose
Fasting
Humans
Insulin
Time Factors

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01480843Simplified Insulin Protocol Using Lantus in ElderlyBackground

Source ClinicalTrials.gov

Download CSV of trials

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11133173Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.J Clin Invest1975https://conductscience.org/library/papers/1133173PubMed
21239396Radioimmunological determination of human C-peptide in serum.Diabetologia1975https://conductscience.org/library/papers/1239396PubMed
3873093B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment.Diabetologia1977https://conductscience.org/library/papers/873093PubMed
44318774Identification of proinsulin and C-peptide in human serum by a specific immunoassay.Proc Natl Acad Sci U S A1970https://conductscience.org/library/papers/4318774PubMed
5830892Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity.J Pediatr1977https://conductscience.org/library/papers/830892PubMed
6326604C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.Diabetes1977https://conductscience.org/library/papers/326604PubMed
7824496Human C-peptide. Part II: Clinical studies.Klin Wochenschr1976https://conductscience.org/library/papers/824496PubMed
8986357Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin.Hoppe Seylers Z Physiol Chem1976https://conductscience.org/library/papers/986357PubMed
91001852C-peptide in children with juvenile diabetes. A preliminary report.Diabetologia1976https://conductscience.org/library/papers/1001852PubMed

Download CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.

PMIDTitleJournalYearIn PapersSource
34637185Impact of flash glucose monitoring on glycemic control varies with the age and residual β-cell function of patients with type 1 diabetes mellitus.J Diabetes Investig2022https://conductscience.org/library/papers/34637185PubMed
33475138Islet Function and Insulin Sensitivity in Latent Autoimmune Diabetes in Adults Taking Sitagliptin: A Randomized Trial.J Clin Endocrinol Metab2021https://conductscience.org/library/papers/33475138PubMed
30919585
Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
J Diabetes Investig2019https://conductscience.org/library/papers/30919585PubMed
29396758Insulin sensitivity and secretion and adipokine profile in patients with Cushing's disease treated with pasireotide.J Endocrinol Invest2018https://conductscience.org/library/papers/29396758PubMed
26849676C-Peptide Level in Fasting Plasma and Pooled Urine Predicts HbA1c after Hospitalization in Patients with Type 2 Diabetes Mellitus.PLoS One2016https://conductscience.org/library/papers/26849676PubMed
24843713Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function.J Diabetes Investig2013https://conductscience.org/library/papers/24843713PubMed
24843526Analysis of factors influencing postprandial C-peptide levels in Japanese patients with type 2 diabetes: Comparison with C-peptide levels after glucagon load.J Diabetes Investig2011https://conductscience.org/library/papers/24843526PubMed
24843502Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.J Diabetes Investig2011https://conductscience.org/library/papers/24843502PubMed
23111058Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.Diabetes Care2013https://conductscience.org/library/papers/23111058PubMed
7047275Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.Diabetologia1982https://conductscience.org/library/papers/7047275PubMed
7026333
Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
Diabetologia1981https://conductscience.org/library/papers/7026333PubMed
7026327Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.Diabetologia1981https://conductscience.org/library/papers/7026327PubMed
7021291The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.Diabetologia1981https://conductscience.org/library/papers/7021291PubMed
7005567[Long-term follow-up study of C-cell-function after partial duodenopancreatectomy (author's transl)].Langenbecks Arch Chir1980https://conductscience.org/library/papers/7005567PubMed
6993546Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.J Endocrinol Invest1980https://conductscience.org/library/papers/6993546PubMed
6989887Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.J Endocrinol Invest1980https://conductscience.org/library/papers/6989887PubMed
6397028Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.Acta Diabetol Lat1984https://conductscience.org/library/papers/6397028PubMed
6341142Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.Diabetologia1983https://conductscience.org/library/papers/6341142PubMed
6182047B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function.Diabetologia1982https://conductscience.org/library/papers/6182047PubMed
3894138C-peptide measurement in the differentiation of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.Diabetologia1985https://conductscience.org/library/papers/3894138PubMed

See all 27 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GCG2641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/338408

GET https://conductscience.org/api/papers/v1/338408/cited_by?page=2